CTNNB1 and hepatocellular carcinoma: The Wnt/β-catenin signalling pathway activates in 20%–35% of HCC cases (Jemal et al., 2010), primarily due to mutations in critical genes like CTNNB1, Axin, and APC (Xu et al., 2022).